A
$ Value
$0
Shares
32,000
Price
$0
Filed
Feb 25
Insider
Name
Schilke Tobin
Title
Chief Financial Officer
CIK
0001678984
Roles
Officer
Transaction Details
Transaction Date
2026-02-23
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
84,834
Footnotes
The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 1, 2027. | Includes 834 shares acquired under the Issuer's Employee Stock Purchase Plan. | The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 23, 2026.
Filing Info
Schilke Tobin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-03 | CRNX | ▼ | $266K |
| 2026-02-23 | CRNX | A | $0 |
| 2026-02-23 | CRNX | A | $0 |
Other Insiders at CRNX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Vivaldi Coelho Rogerio | — | $181K | 2026-03-12 |
|
Schilke Tobin
Chief Financial Officer
|
— | $266K | 2026-03-03 |
| Okey Stephanie | — | $119K | 2026-03-03 |
|
Struthers Richard Scott
President & CEO
|
— | $822K | 2026-03-16 |
|
Knight Jeff E.
Chief Dev. & Operating Officer
|
— | $3.4M | 2026-04-08 |
|
Knight Jeff E.
Chief Operating Officer
|
— | $370K | 2026-03-16 |
|
Betz Stephen F.
Chief Scientific Officer
|
— | $397K | 2026-03-16 |
|
Kalofonos Isabel
Chief Commercial Officer
|
— | — | 2026-02-23 |